Spinal muscular atrophy is a genetic disorder characterized by weakness and wasting (atrophy ) in muscles used for movement (skeletal muscles). It is caused by a loss of specialized nerve cells, called motor neurons that control muscle movement.
What kind of disease is spinal muscular atrophy?
Spinal muscular atrophy (SMA) is a genetic (inherited) neuromuscular disease that causes muscles to become weak and waste away. People with SMA lose a specific type of nerve cell in the spinal cord (called motor neurons) that control muscle movement.
What is Werdnig Hoffmann disease?
Werdnig-Hoffmann disease, which is also known as spinal muscular atrophy type 1 (SMA1) or acute spinal muscular atrophy, refers to individuals who have symptom onset prior to 6 months of age. SMA 2 patients will show symptoms prior to age 1 year, will sit but never walk.
What is the treatment for Kennedy’s disease?
Currently there is no known cure for Kennedy’s disease. Treatment is symptomatic and supportive. Physical therapy and rehabilitation to slow muscle weakness and atrophy may prove helpful. Kennedy’s disease is an inherited motor neuron disease that affects males.
Can females get Kennedy’s disease?
Kennedy disease affects fewer than 1 in 350,000 males and does not typically occur in females, who are protected by their low levels of circulating testosterone, accounting for the sex-limited inheritance pattern in this disorder.
What is SMA type2?
Spinal muscular atrophy type 2 (SMA2) is a genetic neuromuscular disorder that affects the nerve cells that control voluntary muscles (motor neurons). Without treatment, progressive muscle weakness develops in babies with SMA2 between ages 6 and 12 months.
How SMA is diagnosed?
genetic blood tests, which can confirm the diagnosis of SMA. an electromyography (EMG) test that measures the electrical activity of a muscle or a group of muscles (in some cases) a creatine kinase (CPK) test (to distinguish from other types of neuromuscular diseases, if necessary)
Is SMA disease curable?
It’s not currently possible to cure spinal muscular atrophy (SMA), but research is ongoing to find new treatments. Treatment and support is available to manage the symptoms and help people with the condition have the best possible quality of life.
What is SMA disease symptoms?
muscle weakness and decreased muscle tone. limited mobility. breathing problems. problems eating and swallowing.
What is the treatment for Hoffman’s disease?
Treatment / Management There is no cure for Werdnig-Hoffmann disease. Nusinersen is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide, and FDA approved for the treatment of SMA in adult and pediatric patients. It is administered intrathecally.
What is the Kugelberg Welander syndrome?
Kugelberg Welander syndrome is a milder type of spinal muscular atrophy. It is a rare inherited neuromuscular disorder characterized by wasting and weakness in the muscles of the arms and legs, leading to walking difficulties in, and eventual loss of ambulation. Symptoms of Kugelberg Welander syndrome occur after 12 months of age.
What did Beatrice Welander contribution to neurology?
Welander became a professor of neurology at Umeå University from 1964–75. In 1951 Welander was the first to describe the hereditary muscular disease Welander’s distal myopathy, a type of distal muscular dystrophy. Welander is also known for her work with Eric Kugelberg on spinal muscular atrophy (SMA).
What did Esther Welander discover?
In 1951 Welander was the first to describe the hereditary muscular disease Welander’s distal myopathy, a type of distal muscular dystrophy. Welander is also known for her work with Eric Kugelberg on spinal muscular atrophy (SMA). The juvenile manifestation of the disease SMA type III is named after her and her colleague Kugelberg-Welander disease.
Who is Lisa Welander?
Lisa Welander (9 August 1909 – 9 December 2001) was a Swedish neurologist, and was Sweden’s first professor of neurology, taking up her professorship at Umeå University from 1964–75. Welander graduated from Örebro University in 1928, and became a medical licentiate in Stockholm in 1937.
